Lumos Pharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Lumos Pharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Lumos Pharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Lumos Pharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Lumos Pharma Inc (Lumos Pharma) is a clinical-stage biopharmaceutical company. It focuses on the development of innovative treatments for rare diseases. Lumos Pharma's lead product candidate is LUM201, an orally administered small molecule growth hormone secretagogue, which is being developed as a potential treatment for rare endocrine disorders. The company's research candidates are primarily aimed at patients suffering from Pediatric Growth Hormone Deficiency. It is also exploring the potential of LUM201 for treating nonalcoholic fatty liver disease, Idiopathic Short Stature and Prader-Willi Syndrome. Lumos Pharma is headquartered in Austin, Texas, the US.
Headquarters
United States of America
Address
Suite 200, 4200 Marathon Boulevard, Austin, Texas, 78756
Website
www.lumos-pharma.com
Telephone
1 512 2152630
No of Employees
30
Industry
Pharmaceuticals and Healthcare
Lumos Pharma Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline: |
| LUM-201 (ibutamoren): Pediatric Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease |
Competitor Comparison
| Key Parameters | Lumos Pharma Inc | Eli Lilly and Co | Pfizer Inc | Novo Nordisk AS | Teva Pharmaceutical Industries Ltd |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Denmark | Israel |
| City | Austin | Indianapolis | New York City | Bagsvaerd | Tel Aviv |
| State/Province | Texas | Indiana | New York | - | Tel Aviv |
| No. of Employees | 30 | 50,605 | 75,000 | 64,974 | 31,173 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lori D. Lawley | Chief Financial Officer | Senior Management | 2021 | 40 |
| Bradley J. Powers | General Counsel; Chief Compliance Officer | Senior Management | 2015 | 45 |
| Pisit Pitukcheewanont, M.D. | Chief Medical Officer | Senior Management | 2024 | - |
| Campbell Murray | Chairman | Executive Board | - | - |
| John C. McKew, Ph.D. | President; Chief Scientific Officer | Senior Management | 2021 | 59 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer